Plain-English translation of NCT03117946 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers studied how the immune system responds when lung or head and neck cancer patients receive radiation therapy and chemotherapy at the same time. They collected blood samples and tumor tissue from participants at different timepoints to understand how immune cells changed during and after treatment. This research aimed to better understand how these combined treatments work to fight cancer.
When radiation and chemotherapy are given together, doctors want to understand exactly how they work at the cellular level — specifically, how they activate the immune system to attack cancer cells. This knowledge could help doctors improve treatment plans and predict which patients will respond best.
Participants gave blood samples at several timepoints: before treatment started, about 2–3 weeks after starting combined treatment, and then again at 1 month, 3 months, and 12 months after treatment ended. If their cancer returned, they also provided an additional blood sample at that time. Researchers also collected tumor tissue samples when available to study alongside the blood work.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
France